3D Conformal Radiation Therapy — MCQs
Compared to the other options, radiotherapy is LEAST commonly used as a primary treatment modality in:
Which finding excludes BIRADS 3 categorization?
The technique employed in radiotherapy to counteract the effect of tumour motion due to breathing is known as –
For which malignancy is intensity-modulated radiotherapy (IMRT) the most suitable?
Cranial Irradiation" is given for:
In cervical cancer brachytherapy, the primary reference point for dose prescription is -
Which is the treatment of choice for irradiation in Chordoma?
Which radioisotope is commonly used in teletherapy?
For which type of carcinoma is the Nigro protocol primarily used?
Treatment of choice for nasopharyngeal carcinoma T1 is:
3D Conformal Radiation Therapy Indian Medical PG Practice Questions and MCQs
Question 1: Compared to the other options, radiotherapy is LEAST commonly used as a primary treatment modality in:
- A. Esophageal cancer
- B. Brain tumor
- C. Cervical cancer
- D. Stomach cancer (Correct Answer)
Explanation: ***Stomach cancer*** - **Radiotherapy** is generally *not* a primary treatment for **stomach cancer** due to the high radiosensitivity of surrounding organs (e.g., small bowel, liver, kidneys) and the difficulty in delivering a curative dose without significant toxicity. - While it may be used as an **adjuvant therapy** post-surgery or for **palliative care** (e.g., pain, bleeding), it is rarely the initial standalone treatment. *Esophageal cancer* - **Radiotherapy** is a common primary or neoadjuvant treatment for **esophageal cancer**, often in combination with chemotherapy (**chemoradiation**), especially for unresectable cases or to downstage tumors before surgery. - It plays a significant role in both curative intent and **palliative management** for dysphagia. *Brain tumor* - **Radiotherapy** is a cornerstone of treatment for many primary and metastatic **brain tumors**, often following surgical resection or as a standalone primary treatment. - Techniques like **stereotactic radiosurgery (SRS)** and **intensity-modulated radiation therapy (IMRT)** allow for precise targeting, minimizing damage to healthy brain tissue. *Cervical cancer* - **Radiotherapy**, particularly external beam radiation therapy (EBRT) combined with **brachytherapy**, is a highly effective primary treatment for **locally advanced cervical cancer**, especially if surgery is not feasible or desired [1]. - It can achieve high cure rates and is often given concurrently with chemotherapy (**chemoradiation**) [1].
Question 2: Which finding excludes BIRADS 3 categorization?
- A. Normal lymph node
- B. Simple cyst
- C. Architectural distortion (Correct Answer)
- D. Focal asymmetry
Explanation: ***Architectural distortion*** - **Architectural distortion** refers to a disruption of the normal breast parenchymal architecture in the absence of a discrete mass, often indicating an underlying malignancy. - This finding is suspicious enough to warrant a recommendation of **biopsy (BI-RADS 4 or 5)**, thus **excluding BI-RADS 3**, which implies a probably benign finding with a low likelihood of malignancy (<2%). - Architectural distortion has a high association with malignancy and cannot be categorized as BI-RADS 3. *Normal lymph node* - A **normal lymph node** within the breast or axilla is a common and benign finding, characterized by an oval shape, fatty hilum, and thin cortex. - Its presence does not increase the suspicion of malignancy and is classified as **BI-RADS 1 or 2** (definitely benign). - This does NOT exclude BI-RADS 3; it is simply a more benign finding. *Simple cyst* - A **simple cyst** is a very common and benign fluid-filled sac, readily identifiable by clear sonographic criteria (anechoic, thin smooth walls, posterior acoustic enhancement). - It is classified as **BI-RADS 2** (benign finding), meaning it is definitely not malignant. - This does NOT exclude BI-RADS 3; it is simply a more benign finding that does not require follow-up. *Focal asymmetry* - **Focal asymmetry** refers to an area of fibroglandular tissue that is visible on only one mammographic projection or is less conspicuous than a mass. - If it has **no associated suspicious features**, it can be appropriately categorized as **BI-RADS 3**, requiring short interval follow-up. - This does NOT exclude BI-RADS 3 categorization.
Question 3: The technique employed in radiotherapy to counteract the effect of tumour motion due to breathing is known as –
- A. Tracking
- B. Gating (Correct Answer)
- C. Modulation
- D. Arc technique
Explanation: ***Gating*** - **Respiratory gating** involves delivering radiation only during specific phases of the patient's breathing cycle when the tumor is within a defined target window. - This technique helps to **minimize the irradiated volume** of healthy tissue by avoiding treatment when the tumor moves out of the planned treatment field. *Tracking* - **Respiratory tracking** involves actively adjusting the radiation beam in real-time to follow the motion of the tumor during breathing. - While it aims to compensate for motion, it is a different mechanism from gating, which involves turning the beam on and off. *Modulation* - **Intensity-modulated radiation therapy (IMRT)** and similar techniques focus on varying the intensity of the radiation beam across the treatment field to conform the dose to the tumor shape. - Modulation addresses dose distribution within a target, rather than directly managing tumor motion due to respiration. *Arc technique* - **Arc therapy** (e.g., VMAT) involves continuous delivery of radiation as the treatment machine rotates around the patient. - This technique optimizes dose delivery angles and conformity but does not inherently counteract tumor motion, although it can be combined with motion management.
Question 4: For which malignancy is intensity-modulated radiotherapy (IMRT) the most suitable?
- A. Lung
- B. Prostate (Correct Answer)
- C. Leukemias
- D. Stomach
Explanation: ***Prostate*** - **IMRT** is highly suitable for prostate cancer due to the prostate's proximity to critical organs like the **rectum and bladder**. - Its ability to conform the **radiation dose tightly** to the tumor while sparing adjacent healthy tissue significantly reduces side effects like **rectal bleeding** or **urinary dysfunction** [1]. *Lung* - While IMRT is used in lung cancer, especially for complex tumors near vital structures, **stereotactic body radiation therapy (SBRT)** is often preferred for early-stage lung cancer due to its high dose delivery over fewer fractions. - The **motion of the lung** during respiration can make precise IMRT delivery challenging without specialized techniques like **gating or tracking**. *Leukemias* - **Leukemias** are systemic diseases involving blood and bone marrow, making localized radiation therapies like IMRT generally unsuitable as a primary treatment. - Treatment for leukemias primarily involves **chemotherapy, targeted therapy, or stem cell transplant**. *Stomach* - **Stomach cancer** often requires larger radiation fields due to tumor spread and nodal involvement, making the precise dose sculpting of IMRT less advantageous compared to its benefits in smaller, well-defined tumors. - The **mobility of the stomach** and surrounding organs can also present challenges for highly conformal radiation delivery.
Question 5: Cranial Irradiation" is given for:
- A. Anaplastic cancer
- B. Squamous cell cancer
- C. Small cell cancer (Correct Answer)
- D. Adenocarcinoma
Explanation: ***Small cell cancer*** - **Cranial irradiation** is often used as prophylactic treatment for **small cell lung cancer (SCLC)** due to its high propensity for early **brain metastasis**. [1] - This therapy aims to eradicate micrometastases in the brain, thereby improving disease-free survival and reducing neurological complications. *Anaplastic cancer* - While anaplastic cancers can metastasize, **prophylactic cranial irradiation (PCI)** is not a standard or primary treatment approach specifically for preventing brain metastases in all anaplastic cancers. - The treatment for anaplastic cancers is highly dependent on the primary tumor type and specific anaplastic features. *Squamous cell cancer* - **Squamous cell carcinoma** (SCC) rarely metastasize to the brain from extracranial primary sites compared to other cancer types like SCLC, and therefore, PCI is not routinely indicated for SCC. - Brain metastases from SCC, when they occur, are typically treated with **stereotactic radiosurgery** or whole brain radiation therapy as therapeutic, not prophylactic, measures. *Adenocarcinoma* - **Adenocarcinoma** from various primary sites (e.g., lung, breast, colon) can lead to brain metastases, but **prophylactic cranial irradiation (PCI)** is not a standard treatment for preventing these. [2] - Treatment for brain metastases from adenocarcinoma usually involves targeted therapies, surgery, or radiation therapy when metastases are already detected.
Question 6: In cervical cancer brachytherapy, the primary reference point for dose prescription is -
- A. Point A (Correct Answer)
- B. Point B
- C. Side walls of pelvis
- D. Point H
Explanation: ***Point A*** - **Point A** is defined as 2 cm lateral to the central canal of the uterus and 2 cm superior to the external os, representing a dose estimation to the **parametrium** and a critical reference for tumoricidal dose. - This point serves as the **primary prescription and reporting point** for brachytherapy in cervical cancer, as it is highly correlated with treatment outcomes and complications. - Established by **ICRU Report 38** as the standard reference point for dose prescription. *Point B* - **Point B** is located 5 cm from the midline (3 cm lateral to Point A) at the level of Point A, and is primarily used to estimate the dose received by the **pelvic side wall** and regional lymphatics. - It provides an indication of dose to structures further from the applicator but is **not the primary prescription point** for the target volume in brachytherapy. *Side walls of pelvis* - The dose to the **side walls of the pelvis** is relevant for assessing potential toxicity to structures like the obturator nerve and external iliac vessels, and for ensuring adequate coverage of pelvic lymph nodes. - While critical for treatment planning, the side walls themselves are not a primary dose prescription point but rather a **region of interest** for dose constraints and coverage. *Point H* - **Point H** represents the reference point for estimating the dose to the **rectum** in brachytherapy, located at the posterior vaginal wall. - While important for assessing **rectal toxicity** and as a dose-limiting structure, Point H is used for reporting organ-at-risk doses, not for primary tumor dose prescription.
Question 7: Which is the treatment of choice for irradiation in Chordoma?
- A. Protons (Correct Answer)
- B. Electrons
- C. Gamma radiation
- D. 3D - CRT
Explanation: ***Protons*** - Proton therapy is the treatment of choice for **chordoma** due to its ability to deliver a high dose of radiation directly to the tumor while minimizing dose to surrounding healthy tissues. - This precision is critical for tumors located near **sensitive structures**, such as the brainstem, spinal cord, or optic nerves, common sites for chordomas. *Electrons* - **Electron therapy** is typically used for superficial tumors because electrons rapidly deposit their energy within the first few centimeters of tissue. - Chordomas are often deeply seated tumors, making electron therapy an unsuitable option for comprehensive treatment. *Gamma radiation* - **Gamma radiation**, as delivered by techniques like **Gamma Knife radiosurgery**, is primarily used for smaller, well-circumscribed intracranial lesions. - While precise, it may not be ideal for the larger, often irregularly shaped chordomas found in the skull base or sacrum, and it lacks the dose-sparing capabilities of proton beams at depth. *3D - CRT* - **3D Conformal Radiation Therapy (3D-CRT)** uses multiple beams to shape the radiation dose to the tumor, offering better conformity than conventional radiation. - However, compared to proton therapy, 3D-CRT still deposits a significant amount of radiation in tissues both distal and proximal to the tumor, leading to a higher risk of side effects, which is particularly concerning for chordomas given their proximity to critical structures.
Question 8: Which radioisotope is commonly used in teletherapy?
- A. Ra-226
- B. Cs-137
- C. Co-60 (Correct Answer)
- D. Ir-192
Explanation: ***Co-60*** - **Cobalt-60** is a widely used radioisotope in teletherapy (external beam radiotherapy) due to its high-energy gamma emissions (1.17 and 1.33 MeV). - Its relatively long half-life of **5.27 years** makes it practical for sustained clinical use in **teletherapy units**. *Ra-226* - **Radium-226** was historically used in brachytherapy but has largely been replaced due to its alpha emissions, which are difficult to shield, and its long-lived radioactive decay products. - Its use for teletherapy is **not common** because of these safety concerns and the availability of more suitable isotopes. *Cs-137* - **Cesium-137** is primarily used in **brachytherapy** and some low-dose rate teletherapy machines for specific applications, but not as commonly as Co-60 for general teletherapy. - Its lower gamma energy (0.662 MeV) and shorter half-life than Co-60 (30.17 years) make it less ideal for the widespread **deep penetration** required in many teletherapy treatments. *Ir-192* - **Iridium-192** is predominantly used in **high-dose-rate (HDR) brachytherapy** for temporary implants, delivering radiation over short periods. - Its relatively short half-life of **73.8 days** and lower average gamma energy make it unsuitable for typical long-term teletherapy external beam applications.
Question 9: For which type of carcinoma is the Nigro protocol primarily used?
- A. Anal (Correct Answer)
- B. Colon
- C. Hepatocellular
- D. Pancreatic
Explanation: ***Correct: Anal carcinoma*** The **Nigro protocol** is the landmark chemoradiation regimen specifically developed for **anal squamous cell carcinoma**. Introduced by Norman Nigro in 1974, it consists of: - **Concurrent chemotherapy** (5-Fluorouracil + Mitomycin C) - **External beam radiotherapy** This protocol revolutionized anal cancer treatment by achieving complete pathological response in the majority of cases, making it the **standard of care** and avoiding the need for abdominoperineal resection (APR) in most patients. It preserves anal sphincter function and has excellent outcomes with 5-year survival rates exceeding 70%. *Incorrect: Colon carcinoma* - Colon cancer is primarily treated with **surgical resection** (hemicolectomy) followed by adjuvant chemotherapy (FOLFOX) in advanced stages - The Nigro protocol is not used for colonic malignancies *Incorrect: Hepatocellular carcinoma* - HCC treatment includes **hepatic resection**, liver transplantation, radiofrequency ablation, or systemic therapy (sorafenib, lenvatinib) - Chemoradiation protocols like Nigro are not the standard approach *Incorrect: Pancreatic carcinoma* - Pancreatic cancer is treated with **Whipple procedure** (pancreaticoduodenectomy) for resectable tumors or chemotherapy regimens like FOLFIRINOX or gemcitabine-based therapy - The Nigro protocol has no role in pancreatic malignancy management
Question 10: Treatment of choice for nasopharyngeal carcinoma T1 is:
- A. Radiation therapy (Correct Answer)
- B. Chemotherapy
- C. Observation
- D. Surgery
Explanation: ***Radiation therapy*** - **Radiation therapy** (RT) is the primary treatment modality for early-stage (T1) nasopharyngeal carcinoma due to the tumor's high radiosensitivity and its anatomical location, which makes surgical resection challenging. - The goal is to deliver a definitive dose of radiation to the tumor with curative intent, often using techniques like intensity-modulated radiation therapy (IMRT) to spare surrounding critical structures. - T1 NPC has excellent cure rates (>90%) with RT alone. *Chemotherapy* - **Chemotherapy** is generally used in combination with radiation for locally advanced nasopharyngeal carcinoma (stage II-IVB) or for metastatic disease, not typically as monotherapy for T1 tumors. - While concurrent chemoradiotherapy improves outcomes in more advanced stages, it's not the primary curative treatment for early-stage disease and adds unnecessary toxicity. *Observation* - **Observation** or watchful waiting is not appropriate for nasopharyngeal carcinoma, even at T1 stage, as NPC is an aggressive malignancy requiring active treatment. - Unlike some indolent tumors, NPC has potential for local progression and early lymphatic spread, necessitating definitive treatment at diagnosis. *Surgery* - **Surgery** plays a very limited role in the primary treatment of nasopharyngeal carcinoma, especially for T1 lesions. - The nasopharynx's deep anatomical location, proximity to skull base, critical neurovascular structures, and the tumor's infiltrative nature make surgical resection technically challenging with high morbidity. - Surgery might be considered for salvage in selected cases of recurrent disease after radiation failure, but it is not the first-line treatment.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free